Apr 3 |
HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME
|
Mar 28 |
Evaluating Harmony Biosciences: Insights From 8 Financial Analysts
|
Mar 26 |
HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE
|
Mar 19 |
Harmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Shares
|
Mar 8 |
10 Biotech Stocks with Huge Potential
|
Feb 28 |
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
|
Feb 23 |
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript
|
Feb 23 |
HRMY vs. TECH: Which Stock Is the Better Value Option?
|
Feb 23 |
Q4 2023 Harmony Biosciences Holdings Inc Earnings Call
|
Feb 22 |
Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript
|